Spyre Therapeutics Inc. (SYRE)

Spyre Therapeutics Inc. (SYRE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $8.7B; returns 1 day -2.2%, 1 week +13.1%, 1 year +303.8%.

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is a clinical-stage biotechnology company dedicated to developing novel therapeutics for patients suffering from inflammatory bowel disease (IBD). The company's primary focus is on creating differentiated antibodies with optimized delivery mechanisms and extended half-lives to improve treatment outcomes for IBD.

Groups SYRE belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Antibody Therapeutics
• Clinical Stage
• Gastroenterology
• Monoclonal Antibodies
• R&D
• Life Sciences

SYRE financial model: income statement, cash flow and balance sheet